Regulatory & Safety

GettyImages/Traitov

OTC makers hit with US FDA warning letters

By Staff Reporter

Two Chinese and one Korean over-the-counter (OTC) drugmakers have received US FDA warnings for violating good manufacturing practice (GMP) regulations for finished pharmaceuticals.